Truncated IL-17RA soluble receptor and methods of using in inflammation

Details for Australian Patent Application No. 2007235212 (hide)

Owner ZymoGenetics, Inc.

Inventors Gao, Zeren; Rixon, Mark W.; Levin, Steven D.; Stevens, Brenda L.

Agent Spruson & Ferguson

Pub. Number AU-A-2007235212

PCT Pub. Number WO2007/117762

Priority 60/772,219 10.02.06 US

Filing date 12 February 2007

Wipo publication date 18 October 2007

International Classifications

C07K 14/54 (2006.01) Peptides having more than 20 amino acids

C07K 14/715 (2006.01) Peptides having more than 20 amino acids

Event Publications

14 August 2008 PCT application entered the National Phase

  PCT publication WO2007/117762 Priority application(s): WO2007/117762

2 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007235213-Methods and compositions for targeting RELT

2007235210-Preparation of gemcitabine